Cadrenal Therapeutics, Inc. — Form 8-K Summary
Business Context and Reporting Period
Cadrenal Therapeutics, Inc. filed a Current Report on Form 8-K dated March 5, 2024. The filing concerns the Company’s continued listing status on The Nasdaq Capital Market and is not a periodic financial report. The Company’s common stock trades under the symbol CVKD.
Financial Metrics and Liquidity
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial statement metrics.
Material Change Versus the Prior Comparable Period
Nasdaq granted the Company’s request for a 180-day extension to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The new deadline is September 3, 2024. The Company had previously received a noncompliance notice on September 6, 2023.
Outlook, Risks, and Unusual Items
- Compliance generally requires a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Nasdaq may require a longer compliance period, generally up to 20 consecutive business days.
- If the Company does not regain compliance by September 3, 2024, Nasdaq is expected to issue a delisting notification.
- The Company may appeal a delisting determination to a Nasdaq hearings panel, but the filing states there is no assurance that an appeal would be successful.
- The Company intends to monitor its closing bid price and may consider available alternatives, including a reverse stock split, if necessary.
- The extension does not immediately affect the listing or trading of CVKD on the Nasdaq Capital Market.
Key Facts for Investors to Verify
- Whether CVKD achieves a minimum $1.00 closing bid price for the required number of consecutive business days by September 3, 2024.
- Whether Nasdaq imposes a compliance period longer than 10 business days.
- Whether the Company pursues a reverse stock split or another measure to regain compliance.
- Whether Nasdaq issues a delisting determination and, if so, the outcome of any appeal.